After mutation, the proliferation, migration, invasion, and tube formation abilities of GBM cells decreased, suggesting that METTL3 might promote GBM progression by enhancing BUD13’s stability via methylation at 1645 site. This evidence concerns the gene METTL3 and glioblastoma.